Tyra Biosciences, Inc.TYRANASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-95.28M
↓ 120% vs avg
Percentile
P0
Near historical low
Streak
6 yr
Consecutive declineContracting
Average
$-43.23M
Historical baseline
PeriodValueYoY Change
TTM$-95.28M-35.3%
2024$-70.44M-38.4%
2023$-50.91M-0.1%
2022$-50.84M-108.3%
2021$-24.41M-202.2%
2020$-8.07M-206.1%
2019$-2.64M-